comparemela.com

Latest Breaking News On - Aptose biosciences inc - Page 1 : comparemela.com

Aptose Biosciences (TSE:APS) Sets New 12-Month Low at $1 26

Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO)’s share price reached a new 52-week low on Friday . The stock traded as low as C$1.26 and last traded at C$1.26, with a volume of 1002 shares. The stock had previously closed at C$1.30. Aptose Biosciences Stock Performance The company has a market capitalization of […]

Aptose Announces Closing of $4 43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Aptose Announces Closing of $4 43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Aptose Biosciences (NASDAQ:APTO) Coverage Initiated at StockNews com

Equities research analysts at StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Several other analysts also recently commented on APTO. HC Wainwright reaffirmed a “buy” rating and set a $23.00 […]

Aptose Announces $4 43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Aptose Announces $4 43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Aptose Announces $4 43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Aptose Announces $4 43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.